Central nervous system tumors: a single center pathology review of 34,140 cases over 60 years
© Chen et al.; licensee BioMed Central Ltd. 2013
Received: 10 October 2012
Accepted: 26 April 2013
Published: 2 May 2013
Tumor epidemiology is a significant part of CNS (central nervous system) tumor studies. Reassessment of original sections can update our knowledge of tumor spectrum. Here, we discuss the features of CNS tumor pathology in a single center.
A total of 34140 cases from 1950 to 2009 were collected; sections from 1990 to 2009 were reassessed according to WHO 2007 classification, and cases from 1950 to 1989 were classified according to the previous pathological diagnosis.
Seven CNS tumor categories during 1990 to 2009 were as follow: neuroepithelial tissue (38.0%), tumors of the meninges (36.5%), tumors of the sellar region (4.1%), germ cell tumors (1.3%), tumors of cranial and paraspinal nerves (13.3%), lymphomas and hematopoietic neoplasm (1.7%), metastatic tumors (5.1%), where histological types by age and sex were diverse. Overall, males exceeded females in distributions of most CNS tumor subtypes, while tumors of the meninges occurred more frequently in females. The case number of lymphomas and hematopoietic neoplasms grew the fastest during the past five years, and the distribution of neuroepithelial tumors remained stable over the past twenty years.
Despite the possibilities of cross sample biases, the data in this series could suggest a similar CNS tumor spectrum as might occur in other developing countries.
KeywordsCentral nervous system tumors Epidemiology Pathological review Single center WHO 2007 classification
Central nervous system (CNS) tumors are not as frequent as tumors of many other sites, such as those of the reparative or digestive systems , but their incidence rate has increased over time. A report from the International Agency for Research on Cancer (IARC) revealed that the worldwide incidence rate of CNS tumors in 2002, which was age-adjusted and considered the standard world population, was 3.7/100,000 persons among males and 2.6/100,000 persons among females. The incidence rates were higher in developed countries (males: 5.8/100,000 persons; females: 4.1/100,000 persons) than in less developed countries (males: 3.0/100,000 persons; females: 2.1/100,000 persons) . In 2008, the rates had risen to 3.8/100,000 persons in males and 3.1/100,000 persons in females, although the incidence rates in developed countries (males: 5.8/100,000 persons; females: 4.4/100,000 persons) still remained higher than those in less developed countries (males: 3.2/100,000 persons; females: 2.8/100,000 persons). An overall increase has been observed throughout the world, especially in less developed countries, which has captured our attention.
The Neurosurgical Department in Huashan Hospital is a main clinical center for neurological diseases in China. In this study, we retrospectively retrieved the neuropathological data obtained from our hospital during the period of 1950-2009 and analyzed the spatiotemporal changes relative to the published data over the past six decades from other countries.
This study was performed at the Neurosurgical Department of the Huashan Hospital, Fudan University. Ethical approval was granted by the ethics committee of Huashan Hospital. The cases in this report were collected from patients who were diagnosed with CNS tumors and who were surgically treated or received biopsies between 1950 and 2009. Due to the loss of the original pathological sections, the cases from 1950 to 1989 could not be reassessed directly. In those cases, crude classifications were performed according to the previous pathological diagnoses that were used and adopted by neurosurgeons and neuropathologists at the time. However, our cases from 1990 to 2009 were reassessed by neuropathologists from the Neuropathology Department of Huashan Hospital according to the standards from the 2007 World Health Organization (WHO) classification .
All the CNS tumors were divided into seven categories: tumors of neuroepithelial tissue; tumors of the cranial and paraspinal nerves; tumors of the meninges; lymphomas and hematopoietic neoplasms; germ cell tumors; tumors of the sellar region; and metastatic tumors. Some differences exist between the WHO 2007 and WHO 2000 classifications; for example, gliomatosis cerebri was newly included in astrocytic tumors, and pilomyxoid astrocytoma was added as a new subtype in pilocytic astrocytoma. Consequently, we reassessed all the pilocytic astrocytoma cases to separate the cases of pilomyxoid astrocytoma from the old histological diagnoses. Extraventricular neurocytoma, papillary glioneuronal tumor, and rosette-forming glioneuronal tumor of the fourth ventricle were added to a neuronal and mixed neuronal-glial tumors subtype. Angiocentric glioma was grouped with other neuroepithelial tumors. For choroid plexus, atypical choroid plexus papilloma was inserted between choroid plexus papilloma and choroid plexus carcinoma .
The WHO classification offers a crude histological grading system, in which each CNS tumor is classified as grade I-IV according to its degree of malignancy. This system can provide an estimate for the prognosis of a patient. In this study, age, sex, and the tumor histological type and grade were systematically recorded. In the detailed classified cases (1990-2009), the gender data were lost for 83 of the patients, and the age data were lost for 180 of the patients, representing 0.30% and 0.65% of the total, respectively. Consequently, we excluded the lost gender or age cases in the statistics of the sample. All the data analyses were performed using SPSS (Statistical Package for the Social Sciences) software.
From 1950 to 1989, 6338 cases could be grouped according to their CNS tumors based on our crude classification. Among these cases, 3530 were male, 2734 were female, and 935 were children and teenagers (age 0-19). Further details are provided in Additional files 1 and 2.
Histological features of 27802 cases from 1990 to 2009
I. Tumors of neuroepithelial tissue
1. Astrocytic tumors
Subependymal giant cell astrocytoma
Giant cell glioblastoma
2. Oligodendroglial tumors
3. Oligoastrocytic tumors
4. Ependymal tumors
5. Choroid plexus tumor
Choroid plexus papilloma
Atypical choroid plexus papilloma
Choroid plexus carcinoma
6. Other neuroepithelial tumors
Chordoid glioma of the third ventricle
7. Neuronal and mixed neuronal-glial tumors
Desmoplastic infantile astrocytoma/ganglioglioma
Dysembryoplastic neuroepithelial tumor
Dysplastic gangliocytoma of cerebellum, Lhermitte-Duclos
Rosette-forming glioneuronal tumor of the fourth ventricle
Papillary glioneuronal tumor
8. Tumors of pineal region
Papillary tumor of the pineal region
Pineal parenchymal tumor of intermediate differentiation
9. Embryonal tumors
Atypical teratoid/rhabdoid tumor
II. Tumors of cranial and paraspinal nerves
1. Schwannoma (neurilemoma, neurinoma)
III. Tumors of meninges
1. Tumors of meningothelial cells
Grade I meningothelial cells tumors
2. Mesenchymal tumors
Other Mesenchymal tumors
3. Primarymelanocytic lesions
4. Other neoplasms related to the meninges
IV. Lymphomas and hematopoietic neoplasms
V. Germ cell tumors
2. Embryonal carcinoma
3. Yolk sac tumor
With malignant transformation
6. Mixed germ cell tumors
VI. Tumors of the sellar region
Granular cell tumor
Spindle cell oncocytoma of the adenohypophysis
VII. Metastatic tumors
Histological types by age and sex
Gender differences in morbidity were common in many of the subtypes. From 1962 to 1989, all the CNS tumor subtypes (except tumors of the meninges) occurred more frequently in males (Additional file 1). Additionally, from 1990 to 2009, neuroepithelial tumors (the most common category) were observed more frequently in male patients, with a ratio of 1.47 according to this survey. Tumors of the meninges exhibited a female/male ratio that exceeded 1.7 according to our data (Table 1), whereas males were more susceptible to germ cell tumors, with a ratio of 2.91.
Distributions of CNS tumors and top 4 subtypes among children and teenagers (age 0-19)
Tumors of neuroepithelial tissue
Tumors of the sellar region
Tumors of the meninges
Germ cell tumors
Tumors of cranial and paraspinal nerves
Lympnomas and hematopoietic neoplasms
Time trends over the 60-year period
A retrospective epidemiological review of brain tumors is particularly important for future research because it can demonstrate the changes in the tumor spectrum of a population, reveal possible risk factors, and indicating potential therapy methods. China is the most populous country in the world, but it has not yet established a national incidence rate for CNS tumors. Over the past 20 years, acknowledged improvements have occurred in the economy and medical services in China, with concurrent environmental and lifestyle changes. Therefore, the epidemiological characteristics of China can be helpful for a worldwide study and may help predict possible future changes in undeveloped areas as they undergo development. Finally, because of the differences that are present in each classification edition, the reassessment of past cases is required to update our knowledge of CNS tumors.
The distribution of CNS tumor categories found in this study did not exactly replicate the rates observed in previously published worldwide reports. Despite the selection bias inherent in this single-center study, tumors of neuroepithelial tissue and the meninges were the two most common categories; the proportions were 38.0% and 36.5%, respectively. A nationwide database in France revealed that the proportions of these two categories were 53.9% and 28.8%, respectively, from 2004-2008 , whereas another population-based report from CBTRUS (Central Brain Tumor Registry of the United States) recorded rates of 33.7% and 35.5%, respectively, from 2004-2007 . The reason for this great variation remains unknown and requires further investigation.
The tumor spectra varied from adults to children and teenagers as well as from males to females. According to the CBTRUS data, glioblastoma (17.7%) and anaplastic astrocytoma (2.1%) were the most common malignant tumors in adults. In this study population, metastatic tumor, glioblastoma, and anaplastic astrocytoma a larger proportion in adults, whereas medulloblastoma, germ cell tumors, and glioblastoma were more common among children and teenagers.
Proportions of top CNS tumor subtypes among children and teenagers in different regions
Germ cell tumors
Wong et al. 
Makino et al. 
Asirvatham et al. 
Bauchet et al. 
Pinho et al. 
Overall, a larger proportion of males had malignant CNS tumors across all the age groups in this limited population. Data from CBTRUS also revealed a male/female incidence ratio of 1.38 during 2003-2007. For the neuroepithelial tumors, the ratio (male/female) was 1.47 compared to 1.25 (2004-2007) from CBTRUS. Therefore, according to this survey and to other regional studies [13–18], it can be assumed that males tend to have a higher incidence of CNS tumors. Because of the high incidence of neuroepithelial tumors in men, gender difference could be a starting research point that may lead to some valuable findings with respect to tumor origins and chemotherapy. Gender difference found for meninges tumors in our survey was also striking, although we found a ratio (female/male) of only 1.7 compared to the 2.68 ratio based on the CBTRUS data (2004-2007). However, due to the widespread use of advanced diagnostic technologies in China, we predict that this ratio will increase in the near future.
For children and teenagers, the male/female ratio for CNS tumors was 1.66 in the selected cases. Other studies around the world have reported similar ratios: 1.1 in France (population-based study), 1.31 in Japan (population-based study), and 1.27 in Brazil (single-center study) [9, 10, 12]. From our data, males accounted for 74.4% of the germ cell tumors in the pediatric cases, a percentage that was similar to the 69.6% reported by CBTRUS and to those reported by other studies from various regions [8–12], indicating that intrinsic factors also play important roles in oncogenesis.
Several studies have also revealed an increasing trend in the incidence rate for CNS tumors in western countries. In the United States, a population-based series showed that the annual percent change (APC) was +1.1% from 1985-1999 , whereas in France, an APC of +2.33% was observed from 2000 to 2007 . Clinically silent CNS tumors have been identified in a larger proportion of the population, particularly among the elderly, because of improved imaging techniques [17, 20]. Furthermore, the increasing trend was more prominent among certain CNS tumor subtypes [17, 21–23]. xThe increased incidences of gliomas and meningiomas were suspected to have resulted from the widespread use of cell phones since the mid-1990s, but no causal association was confirmed [24, 25]. A larger sample size, a uniform method of classification, and a longer observation time are necessary before we can reach a definitive conclusion.
In China, a fast-growing and developing country, increasing tumor morbidity has been blamed as one of the top three causes of death , just as in most western countries. Because it was not a population-based study, the APC in this series reached +11.22%. In part, this increase could be the result of the increase in hospital size, with the increased number of cases due to more sickrooms and operating rooms, improved neurosurgical techniques making more cases operable and treatable, and economic developments that result in more affordable therapy for most patients. Another key reason might be associated with an increased detection rate of CNS tumors after the widespread use of CT and MRI in both rural and urban areas in China, which reinforced the referral bias. In the early 1980s, the first CT machine was imported into Huashan hospital; this was also the first CT machine in China. In the late 1980s, the first MRI followed. Those machines contributed greatly to the diagnosis of CNS tumors, and from Additional file 3, we indeed observe a continuous increase in the number of cases during that period. Moreover, because the textile industry was booming in a developing China during the 1980s, women constituted the majority of textile workers. Therefore, occupation-related risk factors were simultaneously raised, and a case–cohort study showed a higher brain tumor incidence in female textile workers during that period in Shanghai . The agreement with this data series suggests that the large and detailed database from our sample is very valuable because it reveals how quickly the CNS tumor spectrum changed in China with respect to the affected population characteristics.
The diverse growth rates of the CNS tumor subtypes are also very worthy of consideration. The fastest growing categories of tumors in this study included lymphomas, germ cell tumors, and tumors of the meninges. Lymphoma has been ranked as one of the top ten malignant tumors in this century, and it has the fastest growing incidence rate of all malignant tumors in China . Despite the inherent biases, certain chemical pollutants should be carefully considered [28, 29]. Germ cell tumors are also thought to be closely related to environmental factors. They exhibit a considerable geographical variation in incidence, representing 3-15% of all primary pediatric intracranial neoplasms . Reports from Japan revealed a step-up increase in the incidence from 1980 to 1993 and indicated that winter-born children were more susceptible [31, 32]. For the tumors of the meninges, increasing trends were observed around the world [13, 17, 19, 21–23, 31], and improvements in the diagnostic technologies are still considered to be the major causal factor. Worldwide studies have also demonstrated an apparently increased incidence of metastatic tumors , but this increase was less prominent in our series. The difference might be an artifact of this investigation, as this is a pathological-based review; thus, brain metastasis could have been detected earlier and have been well controlled by radiosurgery without pathological proof. According to our study, most of the fastest increasing subtypes were also malignant, which underscored our need to be more cautious. Therefore, we need more large-scale population-based studies to identify the real risk factors.
As a single-center retrospective series, the data in this study could not represent the national epidemiology of CNS tumors. The pathological diagnoses included in this study were only from patients under surgery or biopsy. Furthermore, surgical treatments were not commonly used in some advanced malignant tumors. Therefore, the distribution of some of the tumor subtypes might be artificially high or low due to the unclear denominator. In brief, various biases were unavoidable in this study, which means that the conclusions should be evaluated with caution.
This study retrospectively analyzed a large-scale and long-term pathological database from a single neurological center. Although it was not a large population study, and a selection bias inevitably existed, the rapidity of the observed changes in the CNS tumor spectrum with respect to the affected population characteristics in China could model similar changes that will occur in other developing countries.
This study was funded by Project supported by the National Science Foundation for Distinguished Young Scholars of China (Grant No. 81100860). We thank all the clinicians of the Neuropathology Department of Huashan Hospital who contributed to the reassessment of the large number of sections, and all the clinicians who contributed to data collection.
- He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen CS, Chen J, Wildman RP, Klag MJ, Whelton PK: Major causes of death among men and women in China. N Engl J Med. 2005, 353 (11): 1124-1134. 10.1056/NEJMsa050467.View ArticlePubMed
- Ferlay J, Bray F, Pisani P, Parkin DM: GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide, version 2.0. IARC cancerbase no. 5. 2004, IARC: Lyon
- Louis DN, Ohgaki H, Wiestler OD, Cavenee WK: WHO classification of tumours of the central nervous system. 2007, Lyon: IARC
- Rousseau A, Mokhtari K, Duyckaerts C: The 2007 WHO classification of tumors of the central nervous system - what has changed?. Curr Opin Neurol. 2008, 21 (6): 720-727. 10.1097/WCO.0b013e328312c3a7.View ArticlePubMed
- Rigau V, Zouaoui S, Mathieu-Daudé H, Darlix A, Maran A, Trétarre B, Bessaoud F, Bauchet F, Attaoua R, Fabbro-Peray P, Fabbro M, Kerr C, Taillandier L, Duffau H, Figarella-Branger D, Costes V, Bauchet L: French brain tumor database: 5-year histological results on 25 756 cases. Brain Pathol. 2011, 21 (6): 633-644. 10.1111/j.1750-3639.2011.00491.x.View ArticlePubMed
- CBTRUS Statistical Report: Primary brain and central nervous system tumors diagnosed in the united states in. 2004,http://www.cbtrus.org/2011-NPCR-SEER/WEB-0407-Report-3-3-2011.pdf, -2007.,
- Bao PP, Zheng Y, Wang CF, Gu K, Jin F, Lu W: Time trends and characteristics of childhood cancer among children age 0-14 in Shanghai. Pediatr Blood Cancer. 2009, 53 (1): 13-16. 10.1002/pbc.21939.View ArticlePubMed
- Asirvatham JR, Deepti AN, Chyne R, Prasad MS, Chacko AG, Rajshekhar V, Chacko G: Pediatric tumors of the central nervous system: a retrospective study of 1,043 cases from a tertiary care center in South India. Childs Nerv Syst. 2011, 27 (8): 1257-1263. 10.1007/s00381-011-1407-z.View ArticlePubMed
- Bauchet L, Rigau V, Mathieu-Daudé H, Fabbro-Peray P, Palenzuela G, Figarella-Branger D, Moritz J, Puget S, Bauchet F, Pallusseau L, Duffau H, Coubes P, Trétarre B, Labrousse F, Dhellemmes P: Clinical epidemiology for childhood primary central nervous system tumors. J Neurooncol. 2009, 92 (1): 87-98. 10.1007/s11060-008-9740-0.View ArticlePubMed
- Pinho RS, Andreoni S, Silva NS, Cappellano AM, Masruha MR, Cavalheiro S, Vilanova LC: Pediatric central nervous system tumors: a single-center experience from 1989 to 2009. J Pediatr Hematol Oncol. 2011, 33 (8): 605-609. 10.1097/MPH.0b013e31822031d9.View ArticlePubMed
- Wong TT, Ho DM, Chang KP, Yen SH, Guo WY, Chang FC, Liang ML, Pan HC, Chung WY: Primary pediatric brain tumors: statistics of Taipei VGH, Taiwan (1975-2004). Cancer. 2005, 104 (10): 2156-2167. 10.1002/cncr.21430.View ArticlePubMed
- Makino K, Nakamura H, Yano S, Kuratsu J: Population-based epidemiological study of primary intracranial tumors in childhood. Childs Nerv Syst. 2010, 26 (8): 1029-1034. 10.1007/s00381-010-1126-x.View ArticlePubMed
- Baldi I, Gruber A, Alioum A, Berteaud E, Lebailly P, Huchet A, Tourdias T, Kantor G, Maire JP, Vital A, Loiseau H: Descriptive epidemiology of CNS tumors in France: results from the gironde registry for the period 2000-2007. Neuro Oncol. 2011, 13 (12): 1370-1378. 10.1093/neuonc/nor120.PubMed CentralView ArticlePubMed
- Filippini G: Epidemiology of primary central nervous system tumors. Handb Clin Neurol. 2012, 104: 3-22.View ArticlePubMed
- Nakamura H, Makino K, Yano S, Kuratsu J: Epidemiological study of primary intracranial tumors: a regional survey in Kumamoto prefecture in southern Japan–20-year study. Int J Clin Oncol. 2011, 16 (4): 314-321. 10.1007/s10147-010-0178-y.View ArticlePubMed
- Lonn S, Klaeboe L, Hall P, Mathiesen T, Auvinen A, Christensen HC, Johansen C, Salminen T, Tynes T, Feychting M: Incidence trends of adult primary intracerebral tumors in four Nordic countries. Int J Cancer. 2004, 108 (3): 450-455. 10.1002/ijc.11578.View ArticlePubMed
- Staneczek W, Janisch W: Epidemiologic data on meningiomas in East Germany 1961-1986: incidence, localization, age and sex distribution. Clin Neuropathol. 1992, 11 (3): 135-141.PubMed
- Sanai N, Chang S, Berger MS: Low-grade gliomas in adults. J Neurosurg. 2011, 115 (5): 948-965. 10.3171/2011.7.JNS101238.View ArticlePubMed
- Hoffman S, Propp JM, McCarthy BJ: Temporal trends in incidence of primary brain tumors in the United States, 1985-1999. Neuro Oncol. 2006, 8 (1): 27-37. 10.1215/S1522851705000323.PubMed CentralView ArticlePubMed
- Nakasu S, Hirano A, Shimura T, Llena JF: Incidental meningiomas in autopsy study. Surg Neurol. 1987, 27 (4): 319-322. 10.1016/0090-3019(87)90005-X.View ArticlePubMed
- Christensen HC, Kosteljanetz M, Johansen C: Incidences of gliomas and meningiomas in Denmark, 1943 to 1997. Neurosurgery. 2003, 52 (6): 1327-1333. 10.1227/01.NEU.0000064802.46759.53. discussion 1333-1324View ArticlePubMed
- Greig NH, Ries LG, Yancik R, Rapoport SI: Increasing annual incidence of primary malignant brain tumors in the elderly. J Natl Cancer Inst. 1990, 82 (20): 1621-1624. 10.1093/jnci/82.20.1621.View ArticlePubMed
- Klaeboe L, Lonn S, Scheie D, Auvinen A, Christensen HC, Feychting M, Johansen C, Salminen T, Tynes T: Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968-1997. Int J Cancer. 2005, 117 (6): 996-1001. 10.1002/ijc.21255.View ArticlePubMed
- Aydin D, Feychting M, Schüz J, Tynes T, Andersen TV, Schmidt LS, Poulsen AH, Johansen C, Prochazka M, Lannering B, Klæboe L, Eggen T, Jenni D, Grotzer M, Von der Weid N, Kuehni CE, Röösli M: Mobile phone use and brain tumors in children and adolescents: a multicenter case–control study. J Natl Cancer Inst. 2011, 103 (16): 1264-1276. 10.1093/jnci/djr244.View ArticlePubMed
- Deltour I, Johansen C, Auvinen A, Feychting M, Klaeboe L, Schuz J: Time trends in brain tumor incidence rates in Denmark, Finland, Norway, and Sweden, 1974-2003. J Natl Cancer Inst. 2009, 101 (24): 1721-1724. 10.1093/jnci/djp415.View ArticlePubMed
- Gold LS, De Roos AJ, Ray RM, Wernli K, Fitzgibbons ED, Gao DL, Astrakianakis G, Feng Z, Thomas D, Checkoway H: Brain tumors and occupational exposures in a cohort of female textile workers in Shanghai, China. Scand J Work Environ Health. 2006, 32 (3): 178-184. 10.5271/sjweh.996.View ArticlePubMed
- Zhang SW, Lei ZL, Li GL, Zou XN, Zhao P, Chen WQ: A report of cancer incidence and mortality from 34 cancer registries in china, 2006. Zhong Guo Zhong Liu. 2010, 19: 356-365.
- Cooper GS, Scott CS, Bale AS: Insights from epidemiology into dichloromethane and cancer risk. Int J Environ Res Public Health. 2011, 8 (8): 3380-3398.PubMed CentralView ArticlePubMed
- Vinson F, Merhi M, Baldi I, Raynal H, Gamet-Payrastre L: Exposure to pesticides and risk of childhood cancer: a meta-analysis of recent epidemiological studies. Occup Environ Med. 2011, 68 (9): 694-702. 10.1136/oemed-2011-100082.View ArticlePubMed
- Jorsal T, Rorth M: Intracranial germ cell tumours. A review with special reference to endocrine manifestations. Acta Oncol. 2012, 51 (1): 3-9. 10.3109/0284186X.2011.586000.View ArticlePubMed
- Kaneko S, Nomura K, Yoshimura T, Yamaguchi N: Trend of brain tumor incidence by histological subtypes in Japan: estimation from the brain tumor registry of Japan, 1973-1993. J Neurooncol. 2002, 60 (1): 61-69. 10.1023/A:1020239720852.View ArticlePubMed
- Makino K, Nakamura H, Hide T, Kuratsu J: Risk of primary childhood brain tumors related to season of birth in Kumamoto Prefecture. Japan. Childs Nerv Syst. 2011, 27 (1): 75-78. 10.1007/s00381-010-1235-6.View ArticlePubMed
- Alexandru D, Bota DA, Linskey ME: Epidemiology of central nervous system metastases. Prog Neurol Surg. 2012, 25: 13-29.View ArticlePubMed
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6890/13/14/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.